Pharmacogenetics of Anti-Diabetes Drugs
A variety of treatment modalities exist for individuals with type 2 diabetes mellitus (T2D). In addition to dietary and physical activity interventions, T2D is also treated pharmacologically with nine major classes of approved drugs. These medications include insulin and its analogues, sulfonylureas...
Main Authors: | Johanna K. DiStefano, Richard M. Watanabe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-08-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/8/2610/ |
Similar Items
-
The role of pharmacogenetics in the treatment of diabetes mellitus
by: Topić Elizabeta
Published: (2014-01-01) -
Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus
by: Hector E. Sanchez-Ibarra, et al.
Published: (2018-04-01) -
Pharmacogenetics of antidepressant response: An update
by: Drago Antonio, et al.
Published: (2009-04-01) -
Noninsulin pharmacological management of type 1 diabetes mellitus
by: Vishvas Garg
Published: (2011-01-01) -
Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
by: Jaehyun Bae, et al.
Published: (2021-05-01)